Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm

Haematologica

Volumn 94, Issue 2, 2009, Pages 285-288

  Facchetti, Fabio ^a   Pileri, Stefano A ^b   Agostinelli, Claudio ^b   Martelli, Maria Paola ^c   Paulli, Marco ^d   Venditti, Adriano ^e   Martelli, Massimo F ^c   Falini, Brunangelo ^c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Acute myeloid leukemia; Antibodies; Immunohistochemistry; Mutations; NPM1; Nucleophosmin; Plasmacytoid dendritic cells

Indexed keywords

NUCLEOPHOSMIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; DENDRITIC CELL SARCOMA; FEMALE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE;

BLAST CRISIS; CLASSIFICATION; CYTOPLASM; DENDRITIC CELLS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEUKEMIA, MYELOID, ACUTE; MYELOPROLIFERATIVE DISORDERS; NUCLEAR PROTEINS; WORLD HEALTH ORGANIZATION;

EID: 59449107134     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13855     Document Type: Article

References (21)

1. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005;352:254-66.
2. Falini B, Nicoletti I, Martelli MF, Mecucci C. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features. Blood 2007; 109:874-85.
3. Falini B, Nicoletti I, Bolli N, Martelli MP, Liso A, Gorello P, et al. Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. Haematologica 2007;92: 519-32.
4. Liso A, Castiglione F, Cappuccio A, Stracci F, Schlenk RF, Amadori S, et al. A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1). Haematologica 2008;93:1219-26.
5. Falini B, Martelli MP, Bolli N, Bonasso R, Ghia E, Pallotta MT, et al. Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia. Blood 2006; 108:1999-2005.
6. Liso A, Bogliolo A, Freschi V, Martelli MP, Pileri SA, Santodirocco M, et al. In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML. Leukemia 2008; 22:1285-9.
7. Falini B, Martelli MP, Mecucci C, Liso A, Bolli N, Bigerna B, et al. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice. Haematologica 2008; 93:775-9.
8. Falini B, Mecucci C, Saglio G, Lo Coco F, Diverio D, Brown P, et al. NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. Haematologica 2008;93: 439-42.
9. Alcalay M, Tiacci E, Bergomas R, Bigerna B, Venturini E, Minardi SP, et al. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance. Blood 2005; 106:899-902.
10. Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C, et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 2008;105:3945-50.
11. Facchetti F, Jones D, Petrella T. Blastic plasmacytoid dendritic cell neoplasm. In: Swerdlow SH et al., editors. WHO Classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC press; 2008. p.145-7.
12. Marafioti T, Paterson JC, Ballabio E, Reichard KK, Tedoldi S, Hollowood K, et al. Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood 2008;111:3778-92.
13. Pasqualucci L, Li S, Meloni G, Schnittger S, Gattenlohner S, Liso A, et al. NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin? Leukemia 2008;22:1459-63.
14. Shiseki M, Kitagawa Y, Wang YH, Yoshinaga K, Kondo T, Kuroiwa H, et al. Lack of nucleophosmin mutation in patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities. Leuk Lymphoma 2007;48:2141-4.
15. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999;5:919-23.
16. Pasqualucci L, Liso A, Martelli MP, Bolli N, Pacini R, Tabarrini A, et al. Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification. Blood 2006;108: 4146-55.
17. Martelli MP, Manes N, Pettirossi V, Liso A, Pacini R, Mannucci R, et al. Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML. Leukemia 2008;22: 195-8.
18. Comeau MR, Van der Vuurst de Vries AR, Maliszewski CR, Galibert L. CD123bright plasmacytoid predendritic cells: progenitors undergoing cell fate conversion? J Immunol 2002;169:75-83.
19. Dijkman R, van Doorn R, Szuhai K, Willemze R, Vermeer MH, Tensen CP. Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities. Blood 2007;109:1720-7.
20. Falini B, Lenze D, Hasserjian R, Coupland S, Jaehne D, Soupir C, et al. Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia 2007; 21:1566-70.
21. Arber DA, Brunning RD, Le Beau MM, Falini B, Vardiman JW, Porwit A, et al. Acute myeloid leukemia with recurrent genetic abnormalities. In: Swerdlow SH et al., editors. WHO Classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC press; 2008. p. 110-23.